|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Investment in equity securities | ||||||||||||||||||||
| Deferred transaction costs | ||||||||||||||||||||
| Promissory notes | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Cash held in trust account | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Pre-acquisition capital project costs | ||||||||||||||||||||
| Capital project costs | ||||||||||||||||||||
| Investment in equity securities | ||||||||||||||||||||
| Right of use asset, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Promissory note – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Extension promissory notes – related party | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued liabilities and other current liabilities | ||||||||||||||||||||
| Current portion of early exercised shares option liability | ||||||||||||||||||||
| Current portion of convertible note | ||||||||||||||||||||
| Current portion of lease liability | ||||||||||||||||||||
| Short term debt | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total short term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| SAFE notes | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Advance from PIPE investor | ||||||||||||||||||||
| Earnout liability | ||||||||||||||||||||
| Other long-term liability | ||||||||||||||||||||
| Convertible note | ||||||||||||||||||||
| Lease liability | ||||||||||||||||||||
| Early exercised shares option liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Class A ordinary shares subject to possible redemption; 134,550 and 3,931,719 shares, respectively (at approximately $11.38 and $11.12 per share at June 30, 2024 and December 31, 2023, respectively) | ||||||||||||||||||||
| Stockholders’ equity (deficit) | ||||||||||||||||||||
| Common stock, $0.0001 par value, 700,000,000 shares authorized, 11,628,657 and 9,869,558 shares issued and outstanding as at June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Total common stock, $0.0001 par value, 700,000,000 shares authorized, 11,628,657 and 9,869,558 shares issued and outstanding as at June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
Loading...
